First Reported Fatalities Associated with the ‘Research Chemical’ 2-Methoxydiphenidine
TLDR
Three deaths which involved the detection of 2-MXP in post-mortem blood and urine were encountered in forensic casework and analytical data is presented to assist analytical toxicologists with future casework.Abstract:
2-Methoxydiphenidine, i.e. 1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine, also known as 'MXP' or '2-MeO-diphenidine' (or 2-MXP), has been available as a 'research chemical' since 2013 as a purported alternative to the 'dissociative anesthetics' methoxetamine and ketamine. Three deaths which involved the detection of 2-MXP in post-mortem blood and urine were encountered in forensic casework. The 2-, 3- and 4-methoxyphenyl positional isomers were synthesized to confirm the identity and concentration of 2-MXP. The 2-MXP femoral blood concentrations in the cases were found to be 24.0, 2.0 and 1.36 mg/L (the latter with an alternative cause of death). Some additional prescription drugs were encountered at therapeutic concentrations in all three cases. Analysis of the biofluids allowed the detection and characterization of various metabolites, including the suggested presence of hydroxy-2-MXP as the main metabolite with the hydroxyl group located on the piperidine rather than the phenyl or benzyl moiety. Additional metabolites included O-desmethyl-2-MXP and hydroxylated O-desmethyl-2-MXP. Diphenidine and hydroxy-diphenidine, also showing the presence of the hydroxyl group on the piperidine ring, were also detected. It was not possible to identify whether these arose from 2-MXP biotransformation or whether they represented the presence of diphenidine as a separate substance. These are the first published fatalities involving 2-MXP and presents analytical data to assist analytical toxicologists with future casework.read more
Citations
More filters
Journal ArticleDOI
Next generation of novel psychoactive substances on the horizon - A complex problem to face.
TL;DR: This review presents updated information on the second generation of NPS, introduced as replacements of the already banned substances from this class, focusing on their pharmacological properties and metabolism, routes of administration, and effects in humans.
Journal ArticleDOI
Ketamine and phencyclidine: the good, the bad and the unexpected
D. Lodge,M S Mercier +1 more
TL;DR: The discovery in 1983 of the NMDA receptor antagonist property of ketamine and phencyclidine was a key step to understanding their pharmacology, including their psychotomimetic effects in man, and its expansion into other hallucinatory drugs.
Journal ArticleDOI
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.
Barry K. Logan,Amanda L A Mohr,Melissa Friscia,Alex J Krotulski,Donna M Papsun,Sherri L. Kacinko,Jeri D. Ropero-Miller,Marilyn A. Huestis +7 more
TL;DR: Recommendations for future toxicological testing of novel psychoactive substances include development and management of a national monitoring program to provide real-time clinical and toxicological data, confirmed analytically, on emerging drugs and their known toxidromes and side effect profiles.
Journal ArticleDOI
Designer drugs: mechanism of action and adverse effects
Dino Luethi,Matthias E. Liechti +1 more
TL;DR: Because of their novelty, designer drugs may remain undetected by routine drug screening, thus hampering evaluations of adverse effects.
Journal ArticleDOI
New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites
Xingxing Diao,Marilyn A. Huestis +1 more
TL;DR: Current SC prevalence is reviewed, the necessity for SC metabolism investigation is established and the advantages and disadvantages of multiple metabolic approaches are compared, and a practical strategy to select optimal urinary marker metabolites for SCs is devised.
References
More filters
Journal ArticleDOI
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate
TL;DR: The results suggest that reduction of synaptic excitation mediated via NMA receptors contributes to the anaesthetic/analgesic properties of these two dissociative anaesthetics.
Journal ArticleDOI
From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.
Hamilton Morris,Jason Wallach +1 more
TL;DR: The first complete portrait of this underground market is presented along with the relevant legal, technological, and scientific developments which have driven its evolution.
Journal ArticleDOI
A 3-year review of new psychoactive substances in casework
Simon P. Elliott,Joanne Evans +1 more
TL;DR: Across all case types and including some cases investigated in 2013, NPS concentrations showed a wide range but these and selected cases are presented to assist toxicological interpretation in future cases.
Journal ArticleDOI
The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor.
Bryan L. Roth,Simon Gibbons,Warunya Arunotayanun,Xi Ping Huang,Vincent Setola,Ric Treble,L. L. Iversen +6 more
TL;DR: The novel ketamine and PCP analogues had significant affinities for the NMDA receptor in radioligand binding assays, which may explain their psychotomimetic effects in human users.
Related Papers (5)
From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.
Hamilton Morris,Jason Wallach +1 more